Mechanisms of tremor induction by harmine.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000470:Alkaloids / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D010134:Fenclonine / Q000494:pharmacology; D006213:Hallucinogens / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006801:Humans; D007211:Indoles / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011725:Pyridines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D051381:Rats; D013223:Statistics as Topic; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced* / Q000378:metabolism
D000470:Alkaloids; D001679:Biogenic Amines; D006213:Hallucinogens; D007211:Indoles; D008781:Methyltyrosines; D010276:Parasympatholytics; D011725:Pyridines; D006916:5-Hydroxytryptophan; D010134:Fenclonine; D004298:Dopamine